H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Transscleral cyclophotocoagulation in the treatment of secondary glaucoma

Rafał Leszczyński, Ariadna Gierek-Lapińska, Maria Formińska - Kapuścik

Med Sci Monit 2004; 10(9): CR542-548

ID: 11769

Published: 2004-09-01


Background:The purpose of this study was to evaluate the results obtained by using transscleral cyclophotocoagulation (TSCPC) in the treatment of refractory secondary glaucoma. Our study attempted to assess the functional effects of TSCPC in different types of secondary glaucoma.Material/Methods: We studied 83 eyes in 81 patients: 52 men and 29 women, aged 9–88 years old (mean 52.8±21.85). Contact transscleral cyclophotocoagulation was performed with an OcuLight SLx photocoagulator using a G probe. The follow-up period was 12 months. All the eyes were photographed for documentation of details.Results: The mean intraocular pressure (IOP) significantly decreased, from 46±12mmHg at baseline to 18±6.4 mmHg (p

Keywords: Eye - pathology, Eye - physiopathology, Glaucoma - etiology, Glaucoma - surgery, Laser Coagulation - adverse effects, Adolescent, Adult, Aged, Aged, 80 and over, Child, Eye - physiopathology, Female, Glaucoma - surgery, Humans, Intraocular Pressure, Laser Coagulation - adverse effects, Male, Middle Aged, Visual Acuity



Back